UltiMaker and Bioactivx Partner for On-Demand Wound Care in ASEAN

A New Era of On-Demand Wound Care in ASEAN \\[n] Desktop 3D printer manufacturer UltiMaker has teamed up with Singaporean MedTech startup Bioactivx to develop a deployable, on-demand 3D printing solution for regenerative wound care. This partnership marks a significant step forward in the medical 3D printing industry, particularly for Southeast Asian factories looking to enhance their healthcare capabilities. \\[n] The collaboration comes at a pivotal moment for Bioactivx, which recently received Health Sciences Authority (HSA) approval for its flagship product, the Bioactiv Matrix. This fully synthetic, animal-free artificial skin substitute is designed to treat severe burns, cuts, and abrasions. The HSA's stringent regulatory standards, recognized by the World Health Organization (WHO), underscore the high quality and reliability of the Bioactiv Matrix. \\[n] ## Implications for ASEAN Factories \\[n] For factories in Thailand, Vietnam, Indonesia, and Malaysia, this development opens up new possibilities in medical manufacturing. The ability to produce high-quality, certified medical devices locally can reduce dependency on centralized manufacturing and cold-chain distribution, leading to faster and more efficient patient care. In Thailand, where the medical device market is rapidly growing, local production could significantly boost the country's healthcare infrastructure. Similarly, in Vietnam and Indonesia, where there is a high demand for advanced medical solutions, this technology can help meet the needs of a large and diverse population. \\[n] ## Advancing Medical 3D Printing \\[n] The Bioactiv Matrix is manufactured through a digital production process built around UltiMaker hardware. Bioactivx compounds a proprietary active-ingredient filament in-house and uses a fleet of UltiMaker 3D printers inside a certified cleanroom facility. This end-to-end process has earned the company both ISO 13485 certification and HSA approval, setting a new standard for 3D-printed medical devices. \\[n] Under the memorandum of understanding (MoU), UltiMaker and Bioactivx will work to refine a 3D printing configuration that can be deployed closer to the point of treatment. This decentralized approach aims to shorten the time between injury and treatment, which is crucial for effective wound care. While specific deployment timelines and unit targets have not been disclosed, the potential benefits are clear: faster access to high-quality medical products, reduced logistical challenges, and improved patient outcomes. \\[n] ## Clinical Applications and Future Prospects \\[n] The application of 3D printing in wound care is already showing promising results. For example, at the University of Toledo Medical Center, physicians used a 3D bioprinter to create patient-specific grafts from a small sample of the patient's own fat tissue. These grafts, tailored to fit the exact dimensions of the wound, have shown rapid healing in clinical trials. \\[n] In another development, Swiss biotech company Cutiss reported positive interim results from phase II clinical trials of denovoSkin, a bilayer skin substitute. The company is planning a European phase III trial and has already provided limited access to patients in the US and Europe under compassionate-use exemptions. \\[n] These advancements highlight the growing role of 3D printing and engineered skin technologies in clinical treatment. For ASEAN factories, the Bioactivx-UltiMaker MoU represents a significant opportunity to enter the medical 3D printing market. By focusing on how an already regulated wound-care product can be manufactured closer to the point of treatment, this partnership addresses key challenges such as production time, scalability, and regulatory requirements. \\[n] ## Takeaway for Factory Buyers \\[n] For factory buyers in ASEAN, the collaboration between UltiMaker and Bioactivx offers a compelling case for investing in 3D printing technology. The ability to produce high-quality, certified medical devices locally can not only enhance the region's healthcare capabilities but also open up new business opportunities. As the medical 3D printing industry continues to grow, early adopters in Thailand, Vietnam, Indonesia, and Malaysia stand to benefit significantly from this innovative partnership.